Winimox-LP Eye Drop BAK Free is a sterile ophthalmic suspension containing Loteprednol etabonate 0.5% w/v, a corticosteroid with potent anti-inflammatory properties, combined with Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic. This formulation is designed to manage ocular inflammatory conditions associated with bacterial infections or to prevent bacterial contamination during inflammatory episodes. Loteprednol etabonate acts by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and discomfort, while Moxifloxacin effectively targets a wide range of gram-positive and gram-negative pathogens, inhibiting bacterial DNA gyrase and topoisomerase IV enzymes essential for bacterial replication. The BAK-free (benzalkonium chloride-free) formulation minimizes preservative-related ocular surface toxicity, making it suitable for patients with sensitive eyes or those requiring prolonged therapy. Winimox-LP Eye Drop BAK Free is indicated for the treatment of steroid-responsive inflammatory ocular conditions where bacterial infection or risk of infection is present, such as postoperative inflammation following ocular surgery or bacterial conjunctivitis with inflammation. It should be used under strict ophthalmologic supervision to monitor for potential corticosteroid-related side effects, including increased intraocular pressure and delayed wound healing. Proper administration and adherence to prescribed dosage are essential for optimal therapeutic outcomes.